摘要
基于欧洲药品管理局(EMA)数据库检索孤儿药相关数据,从年代分布、药品类别、活性成分、公司分布等方面进行分析,探讨孤儿药法规对新药研发的影响,为我国罕见病及孤儿药管理提供参考。
The paper retrieves the orphan drug data from European Medicines Agency (EMA) database. The detailed analysis on or- phan drugs is from aspects as publishing years, drug categories, active ingredients, company distribution and so on, then how legislation on orphan drugs would affect new drug development is discussed, so as to provide references for our country in the rare disease and orphan drug management.
出处
《医学信息学杂志》
CAS
2013年第12期48-51,共4页
Journal of Medical Informatics
基金
2012年度高校哲学社会科学基金项目(2012SJD870012)
关键词
欧盟
罕见病
孤儿药
计量分析
The European Union
Rare diseases
Orphan drug
Bibliometric analysis